REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
05/05/2021 14:55
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210505:nBw8tj09ta&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
Ap19
FORM 8.3 - Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 30 April 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,704,431 1.32% 165,987 0.13%
(2) Derivatives (other than options):
72,359 0.06% 0 0.00%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,782,890 1.38% 172,087 0.13%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 263.1350 USD
Purchase 2 262.0535 USD
Purchase 5 261.1600 USD
Purchase 9 261.5244 USD
Purchase 23 259.3600 USD
Purchase 32 247.6700 USD
Purchase 50 259.2700 USD
Purchase 79 260.9700 USD
Purchase 88 260.8800 USD
Purchase 100 257.2400 USD
Purchase 100 256.6250 USD
Purchase 100 260.5500 USD
Purchase 200 263.0300 USD
Purchase 300 260.6533 USD
Purchase 350 260.4874 USD
Purchase 458 261.4372 USD
Purchase 502 260.5528 USD
Purchase 577 260.4057 USD
Purchase 586 259.2985 USD
Purchase 1,331 262.2107 USD
Purchase 1,435 259.6717 USD
Purchase 1,457 261.1630 USD
Purchase 1,924 259.9086 USD
Purchase 3,919 258.8600 USD
Purchase 5,866 259.9134 USD
Purchase 7,581 260.5190 USD
Purchase 8,618 261.1849 USD
Purchase 11,523 260.5046 USD
Purchase 15,064 260.6826 USD
Purchase 15,809 258.8240 USD
Purchase 51,176 260.6910 USD
Sale 2 263.1350 USD
Sale 4 262.0535 USD
Sale 6 259.6900 USD
Sale 10 261.2192 USD
Sale 10 259.3440 USD
Sale 12 259.0150 USD
Sale 12 259.4475 USD
Sale 18 259.2250 USD
Sale 18 259.2733 USD
Sale 18 259.2433 USD
Sale 20 260.4460 USD
Sale 24 259.4662 USD
Sale 24 259.5900 USD
Sale 30 259.3290 USD
Sale 32 247.6700 USD
Sale 36 259.1983 USD
Sale 50 259.2700 USD
Sale 67 259.2937 USD
Sale 88 260.8800 USD
Sale 100 259.9800 USD
Sale 100 260.9300 USD
Sale 100 259.9600 USD
Sale 100 260.5100 USD
Sale 112 259.2412 USD
Sale 154 260.2603 USD
Sale 184 261.0193 USD
Sale 484 260.4946 USD
Sale 640 260.5325 USD
Sale 1,000 260.5468 USD
Sale 1,037 257.6754 USD
Sale 1,405 259.4726 USD
Sale 1,870 260.5782 USD
Sale 1,984 260.9141 USD
Sale 2,987 260.8073 USD
Sale 3,100 259.3043 USD
Sale 3,427 260.9893 USD
Sale 3,652 260.9759 USD
Sale 3,765 259.3862 USD
Sale 3,817 258.8600 USD
Sale 4,098 260.5722 USD
Sale 4,125 260.6380 USD
Sale 6,176 260.7571 USD
Sale 6,263 260.3581 USD
Sale 6,884 260.5879 USD
Sale 9,179 260.6731 USD
Sale 9,630 258.0454 USD
Sale 11,384 260.8187 USD
Sale 19,926 260.7073 USD
Sale 21,000 260.9159 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 5 May 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210505005687/en/
(https://www.businesswire.com/news/home/20210505005687/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - J.P. Morgan Sec PLC - Stabilisation Notice
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
Announcement